Staples Versus Dermabond for Closure of the Skin After Cesarean Section
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01261715|
Recruitment Status : Unknown
Verified October 2010 by Meir Medical Center.
Recruitment status was: Enrolling by invitation
First Posted : December 16, 2010
Last Update Posted : December 16, 2010
Two of the more frequently used options for skin closure following a cesarean delivery include staples or sutures (stitches). Another method of closure is Dermabond- liquid skin adhesive. This method of closure is used less frequently than either staples or sutures.
Few studies have been done regarding whether Dermabond is preferable or affect the outcome of a cesarean section surgery. The aim of our study is to find weather Dermabond haas better result for the closure of cesarean section wounds.
|Condition or disease||Intervention/treatment||Phase|
|Cesarean Section Wound||Procedure: Dermabond- liquid skin adhesive||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||50 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Staples Versus Dermabond for Closure of the Skin After Cesarean Section|
|Study Start Date :||January 2011|
|Estimated Primary Completion Date :||February 2012|
|Active Comparator: Woman with previous ceasarean section - staples||
Procedure: Dermabond- liquid skin adhesive
Dermabond- liquid skin adhesive
- Cosmetic objective evaluation of the scar [ Time Frame: 6 weeks postoperatively ]
- The difference in pain between the two type of closure [ Time Frame: 1 and 4 days postoperatively ]
- The difference in patient satisfaction with the scar result [ Time Frame: 6 weeks postoperatively ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01261715
|Meir medical center|
|Kfar Saba, Israel|
|Principal Investigator:||Dana Sadeh, MD||MD|